Filing Flows › West Pharmaceutical Services (WST) › West Vantage revenue
West Pharmaceutical Services (WST) West Vantage revenue by quarter
West Pharmaceutical Services' West Vantage revenue was $146M in Q3 2026 (third quarter 2026), -3% from Q2 2026. Over the last 3 quarters it ranged from $146M (Q3 2026) to $151M (Q1 2026).
| Quarter | West Vantage revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $146M | -3% | — |
| Q2 2026 | $150M | -0.6% | — |
| Q1 2026 | $151M | — | — |
Q3 2026 at a glance
West Pharmaceutical Services, Q3 2026: revenue $874M (+9% year over year), operating margin 30.6%, net earnings $214M, operating cash flow $190M. The chart follows the revenue to costs, profit and cash.
Questions
What is West Pharmaceutical Services' West Vantage revenue?
West Pharmaceutical Services' West Vantage revenue was $146M in Q3 2026 (third quarter 2026), -3% from Q2 2026.
How has West Pharmaceutical Services' West Vantage revenue changed?
Over the last 3 quarters it ranged from $146M (Q3 2026) to $151M (Q1 2026).
Q3 2026 results → · How West Pharmaceutical Services makes money →